Clinical trial
Trial of Adjuvant Chemotherapy for Gastric Cancer
NCT00296322 · Asan Medical Center, Other · Completed
Key facts
| NCT number | NCT00296322 |
|---|---|
| Title | Trial of Adjuvant Chemotherapy for Gastric Cancer |
| Official title | A Phase III Randomized Controlled Trial of Adjuvant Chemotherapy for Gastric Adenocarcinoma: Mitomycin and Doxifluridine Versus Intraperitoneal Chemotherapy and Mitomycin, Doxifluridine, and Cisplatin |
| Lead sponsor | Asan Medical Center, Other |
| Collaborators | Ulsan University Hospital Hallym University Medical Center |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Stomach Cancer |
| Intervention type | Drug |
| Interventions | cisplatin, mitomycin-C, doxifluridine |
| Enrollment | 528 |
| Start date | Oct 1, 2001 |
| Primary completion | Dec 1, 2007 |
| Completion | Mar 1, 2010 |
| First posted | Feb 27, 2006 |
| Last update posted | Jan 18, 2020 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: